Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC2 | Q92769 | 4/20 | 0.59 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.33 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.33 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.33 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.33 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | TET2 | Q6N021 | 2/20 | 0.31 |
| ▸ | KDM4A | O75164 | 1/20 | 0.31 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.31 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL11109713 | 0.94 | HDAC2 (0.53) | HDAC2SLC22A6SMN1; SMN2GABRR1LMNA | |
| SCHEMBL28946975 | 0.79 | FPR2 (0.46) | HDAC2FOLH1CYP2D6TET2KDM4A | |
| SCHEMBL6326746 | 0.79 | HDAC2 (0.57) | HDAC2SLC22A6SMN1; SMN2LMNATDP1 | |
| SCHEMBL6326750 | 0.79 | HDAC2 (0.57) | HDAC2SLC22A6SMN1; SMN2LMNATDP1 | |
| SCHEMBL2065565 | 0.76 | HDAC2 (0.63) | HDAC2SLC22A6SMN1; SMN2GABRR1LMNA | |
| SCHEMBL12601342 | 0.76 | HDAC2 (0.63) | HDAC2LMNAHDAC3HDAC1HDAC8 | |
| SCHEMBL2702155 | 0.76 | HDAC2 (0.63) | HDAC2SLC22A6SMN1; SMN2GABRR1LMNA | |
| SCHEMBL63303 | 0.76 | HDAC2 (0.53) | HDAC2SLC22A6SMN1; SMN2GABRR1LMNA | |
| SCHEMBL2518292 | 0.76 | HDAC2 (0.63) | HDAC2SLC22A6SMN1; SMN2GABRR1LMNA | |
| SCHEMBL2065563 | 0.76 | HDAC2 (0.63) | HDAC2SLC22A6SMN1; SMN2GABRR1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2006024885-A1 | PROCESS FOR THE PREPARATION OF POLYISOCYANATE/POLYSILICIC ACID BASED POLYADDITION AND HYBRID RESINS USING BLOCKED POLYISO-CYANATES AND BLOCKED POLYISOCYANATES USABLE IN THE PROCESS | POLINVENT FEJLESZTO, KIVITELEZO ÉS ÉRTÉKESÍTO KFT (HU) | 2006-03-09 | — | — | WO | claimed |
| US-8383274-B2 | Nonaqueous electrolyte solution for lithium battery, lithium battery using same, and formyloxy group-containing compound used therein | UBE INDUSTRIES, LTD. (JP) | 2013-02-26 | — | — | US | disclosed |
| US-20110183199-A1 | NONAQUEOUS ELECTROLYTE SOLUTION FOR LITHIUM BATTERY, LITHIUM BATTERY USING SAME, AND FORMYLOXY GROUP-CONTAINING COMPOUND USED THEREIN | UBE INDUSTRIES, LTD. (JP) | 2011-07-28 | — | — | US | disclosed |
| US-5223601-A | Phenolic compounds containing/neutral fractions extract and products derived therefrom from fractionated fast-pyrolysis oils | MIDWEST RESEARCH INSTITUTE VENTURES, INC. (US) | 1993-06-29 | — | — | US | disclosed |
| EP-0022488-B1 | PROCESS FOR THE PREPARATION OF BUTANE-DIOL DIACETATE BY CATALYTIC HYDROGENATION OF BUTENE-DIOL DIACETATE | BASF Aktiengesellschaft (DE) | 1982-01-20 | — | — | EP | disclosed |
| EP-0009741-B1 | PROCESS FOR THE PREPARATION OF BUTENEDIOL DIESTERS | BASF Aktiengesellschaft (DE) | 1982-01-20 | — | — | EP | disclosed |
| EP-0012367-B1 | METHOD FOR THE PREPARATION OF VINYLGLYCOL ESTERS | BASF Aktiengesellschaft (DE) | 1981-11-11 | — | — | EP | disclosed |
| EP-0010702-B1 | PROCESS FOR THE MANUFACTURE OF BUTENEDIOL DIACETATES AND BUTANEDIOL FROM BUTADIENE | BASF Aktiengesellschaft (DE) | 1981-08-05 | — | — | EP | disclosed |
| EP-0004019-B1 | PROCESS FOR THE PURIFICATION OF EPOXIDES | BAYER AG (DE) | 1981-07-29 | — | — | EP | disclosed |
| EP-0022488-A1 | Process for the preparation of butane-diol diacetate by catalytic hydrogenation of butene-diol diacetate | BASF Aktiengesellschaft (DE) | 1981-01-21 | — | — | EP | disclosed |
| EP-0012367-A1 | Method for the preparation of vinylglycol esters | BASF Aktiengesellschaft (DE) | 1980-06-25 | — | — | EP | disclosed |
| EP-0009741-A1 | Process for the preparation of butenediol diesters | BASF Aktiengesellschaft (DE) | 1980-04-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110183199-A1 | NONAQUEOUS ELECTROLYTE SOLUTION FOR LITHIUM BATTERY, LITHIUM BATTERY USING SAME, AND FORMYLOXY GROUP-CONTAINING COMPOUND USED THEREIN | HCN2, KCNN2, KCNB1 | HDAC2 1485/4885SLC22A6 719/4885SMN1; SMN2 4507/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.